Hui Gong

The development of antiplatelet therapy after percutaneous coronary intervention

H. Duan, Hui Gong, 2017 .

Cilostazol combined with P2Y12 receptor inhibitors: A substitute antiplatelet regimen for aspirin‐intolerant patients undergoing percutaneous coronary stent implantation

Xinping Luo, Jian Li, P. Zhou, 2022, Clinical cardiology.

Relationship between lncRNA-Ang362 and prognosis of patients with coronary heart disease after percutaneous coronary intervention

Hui Gong, Ying-wu Liu, Hui Wang, 2020, Bioscience reports.

Editorial: Ischemic Myocardial Injury and Protection: From Bench to Bedside

Yaoliang Tang, Hongmei Tan, Hui Gong, 2022, Frontiers in Cardiovascular Medicine.

A stricter control of low-density lipoprotein is necessary for thrombosis reduction in “lower thrombosis risk” patients with atrial fibrillation: a multicenter retrospective cohort study

Xinping Luo, Jian Li, P. Zhou, 2020, Journal of Thrombosis and Thrombolysis.

Exploring novel biomarkers in dilated cardiomyopathy‑induced heart failure by integrated analysis and in vitro experiments

Juexing Li, Lei Zhou, Hui Gong, 2023, Experimental and therapeutic medicine.

Association of dynamic change of triglyceride-glucose index during hospital stay with all-cause mortality in critically ill patients: a retrospective cohort study from MIMIC IV2.0

Hairong Wang, Li Lin, Jun Wang, 2023, Cardiovascular Diabetology.